Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Fujian Mobile Communications of China (Fujian MCC) on valinnut Nokian Push to Talk over Cellular (PoC) -ratkaisun tarjotakseen uuden pikaviestintäpalvelun yrityksille Fujianin maakunnassa Kiinassa....
-
Espoo, Finland - Fujian Mobile Communications of China has chosen Nokia's Push to Talk over Cellular (PoC) platform to provide a new, instant communication service to enterprises in Fujian province,...
-
On 11.01.2006 Hunter Hall Investment Management Limited bought 434,118 shares. Balance held at 11th January 06 is 1,855,318 shares, % held as at 11th January 06 is 11.00%....
-
NEW YORK, Jan. 10, 2006 (PRIMEZONE) -- Effective Thursday, Jan. 12, British Airways is introducing its award-winning Club World flat bed as well as the premier economy cabin, World Traveller Plus, on...
-
Nokia Oyj:n ("Nokia") osakkeita on merkitty vuoden 2003 optio-ohjelman optio-oikeuksilla 30.12.2005 mennessä 67 004 kappaletta. Osakepääomaa on korotettu merkinnän johdosta 4 020, 24 eurolla, ja...
-
A total of 67,004 shares of Nokia Corporation ("Nokia") were subscribed for as of December 30, 2005 based on Nokia's 2003 employee stock option plan. This resulted in an increase of EUR 4,020.24 in...
-
Helsinki, Finland / Kyoto, Japan - Kyocera Corporation, along with its subsidiary, Kyocera Wireless Corp., and Nokia Corporation, along with its subsidiary Nokia Inc., today announced that they have...
-
Basel, 10. Januar, 2006 - Nach Abschluss der Unternehmensprüfung und einer Beurteilung der potenziellen Vorteile und Risiken einer Akquisition hat Novartis beschlossen, kein Angebot für die Berna...
-
Basel, January 10, 2006 - After completion of due diligence and an assessment of the potential benefits and risks of an acquisition, Novartis has decided not to make an offer for Berna Biotech...
-
Bâle, le 10 janvier 2006 - Après l'examen des comptes et l'évaluation de l'intérêt et des risques que l'acquisition de la société de vaccins suisse pourrait représenter, Novartis a pris la décision de...